These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 16875614

  • 1. [Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].
    Zhang P, Feng FY, Wu LY, Hu Y, Liu JW, Gao YJ, Guan XQ, Nan KJ, Suo AL, Wang XW, Zhang MH, Zhang WD, Li CW, Zhang Y, Zhao JB.
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):230-4. PubMed ID: 16875614
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].
    Xu RH, Shi YX, Guan ZZ, Jiang WQ, Huang H, Ma ZY, Wang JH, Hu XH, Xie WM, Li XG, Liu YL, Pan LX, Dai AD, Zhuang W, Zhang C.
    Ai Zheng; 2006 Dec; 25(12):1565-8. PubMed ID: 17166388
    [Abstract] [Full Text] [Related]

  • 4. Randomized control study of nedaplatin or cisplatin concomitant with other chemotherapy in the treatment of advanced non-small cell lung cancer.
    Li CH, Liu MY, Liu W, Li DD, Cai L.
    Asian Pac J Cancer Prev; 2014 Dec; 15(2):731-6. PubMed ID: 24568487
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment.
    Kajiura S, Hosokawa A, Yoshita H, Ueda Y, Ueda A, Mihara H, Ando T, Fujinami H, Nishikawa J, Ogawa K, Minemura M, Sugiyama T.
    Am J Clin Oncol; 2016 Feb; 39(1):13-7. PubMed ID: 24322336
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study.
    Yamashita H, Nakagawa K, Tago M, Igaki H, Nakamura N, Shiraishi K, Sasano N, Ohtomo K.
    Dis Esophagus; 2006 Feb; 19(1):15-9. PubMed ID: 16364038
    [Abstract] [Full Text] [Related]

  • 9. Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
    Shukuya T, Yamanaka T, Seto T, Daga H, Goto K, Saka H, Sugawara S, Takahashi T, Yokota S, Kaneda H, Kawaguchi T, Nagase S, Oguri T, Iwamoto Y, Nishimura T, Hattori Y, Nakagawa K, Nakanishi Y, Yamamoto N, West Japan Oncology Group.
    Lancet Oncol; 2015 Dec; 16(16):1630-8. PubMed ID: 26522337
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Nedaplatin].
    Ota K.
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):379-87. PubMed ID: 8712835
    [Abstract] [Full Text] [Related]

  • 13. A phase II trial of docetaxel plus nedaplatin and 5-fluorouracil in treating advanced esophageal carcinoma.
    Guo JF, Zhang B, Wu F, Wang B, Xing H, Zhu GY, Nie XY, Peng J.
    Chin J Cancer; 2010 Mar; 29(3):321-4. PubMed ID: 20193118
    [Abstract] [Full Text] [Related]

  • 14. [Clinical evaluation of DLF, CLF and DFM regimens based on platinum compound plus 5-fluorouracil for treatment of advanced esophageal carcinoma].
    Jiang Y, Qiu XH, Yang YX, Zhang SQ, Chen ZM.
    Ai Zheng; 2006 Aug; 25(8):1029-34. PubMed ID: 16965688
    [Abstract] [Full Text] [Related]

  • 15. [Nedaplatin (NDP)-combination therapy (NDP/5-FU,NDP/S-1) for oral cancer].
    Maruoka Y, Ando T, Ogiuchi Y, Ogiuchi H.
    Gan To Kagaku Ryoho; 2007 May; 34(5):713-7. PubMed ID: 17496443
    [Abstract] [Full Text] [Related]

  • 16. Phase I study of combination chemotherapy with 5-fluorouracil (5-FU) and nedaplatin (NDP): adverse effects and eecommended dose of NDP administered after 5-FU.
    Fuwa N, Kodaira T, Kamata M, Matsumoto A, Furutani K, Tachibana H, Ito Y.
    Am J Clin Oncol; 2002 Dec; 25(6):565-9. PubMed ID: 12477999
    [Abstract] [Full Text] [Related]

  • 17. Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non-small cell lung cancer.
    Igawa S, Otani S, Nakahara Y, Ryuge S, Hiyoshi Y, Fukui T, Mitsufuji H, Kubota M, Katagiri M, Sato Y, Sasaki J, Masuda N.
    Invest New Drugs; 2018 Feb; 36(1):45-52. PubMed ID: 28466376
    [Abstract] [Full Text] [Related]

  • 18. [A randomized controlled trail of taxol-based combination regimens for advanced gastric cancer].
    Yang JW, Chen YG, Chen Q, Fan NF, Guo ZQ, Cai XC, Wu XA, Xu S, Lu X, Zhang YH, Ouyang XN.
    Ai Zheng; 2005 Dec; 24(12):1531-6. PubMed ID: 16351808
    [Abstract] [Full Text] [Related]

  • 19. Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.
    Tang LQ, Chen DP, Guo L, Mo HY, Huang Y, Guo SS, Qi B, Tang QN, Wang P, Li XY, Li JB, Liu Q, Gao YH, Xie FY, Liu LT, Li Y, Liu SL, Xie HJ, Liang YJ, Sun XS, Yan JJ, Wu YS, Luo DH, Huang PY, Xiang YQ, Sun R, Chen MY, Lv X, Wang L, Xia WX, Zhao C, Cao KJ, Qian CN, Guo X, Hong MH, Nie ZQ, Chen QY, Mai HQ.
    Lancet Oncol; 2018 Apr; 19(4):461-473. PubMed ID: 29501366
    [Abstract] [Full Text] [Related]

  • 20. [DNCE regimen for treatment of refractory or relapsed aggressive and highly aggressive non-Hodgkin lymphoma].
    Liu XM, Wang HQ, Zhang HL, Qiu LH, Li W, Li LF, Cui XZ, Liu PF, Hao XS.
    Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):779-82. PubMed ID: 19173813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.